According to the latest report by IMARC Group, titled, “Cloning & Mutagenesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global cloning & mutagenesis market size, share, trends and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the cloning & mutagenesis market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 2.4 Billion |
| Market Forecast in 2028 | US$ 6.4 Billion |
| Growth rate (2023 to 2028) | CAGR of 17.3% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is cloning & mutagenesis?
Cloning and mutagenesis refer to two crucial techniques used in the field of biotechnology. Cloning represents the process of making an identical copy of a Deoxyribonucleic Acid (DNA) sequence, typically using a vector (including a plasmid) to insert the sequence into a host organism (such as bacteria). On the other hand, mutagenesis is often utilized to study the function of specific genes or to create new variants with altered properties. In recent times, these important techniques have gained traction as they are critical tools that have revolutionized numerous areas of biotechnology and have enabled researchers to study genes and proteins for the development of novel therapeutics, agricultural products, and industrial processes.
Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/cloning-mutagenesis-market/requestsample
What are the growth prospects and trends in the cloning & mutagenesis industry?
The growing prevalence of chronic and genetic disorders across the globe is primarily driving the cloning and mutagenesis market. Furthermore, the escalating demand for personalized medicines as they involve tailoring medical treatment to an individual genetic makeup, which is performed through these crucial techniques, is also augmenting the market growth. Apart from this, the widespread adoption of cloning and mutagenesis in the biotechnology and pharmaceutical industries to develop new drugs, vaccines, and therapeutic proteins is positively influencing the global market. Moreover, several advancements in genetic engineering technologies that have made these important techniques more efficient, precise, and cost-effective are further bolstering the market growth. Besides this, the increasing applications of genetically modified organisms (GMOs) in agriculture for producing insect-resistant and herbicide-tolerant seeds and in the medical industry are acting as significant growth-inducing factors. Additionally, government bodies of various countries and private organizations are investing in research and development (R&D) in the biotechnology field, which is expected to drive the cloning and mutagenesis market.
What is included in market segmentation?
The report has segmented the market into the following categories:
Product Insights:
- Cloning Kits
- Mutagenesis Kits
Technology Insights:
- Topo PCR Cloning
- Blunt End Cloning
- Seamless Cloning
- Site-directed Mutagenesis
- Others
End User Insights:
- Biopharmaceutical and Pharmaceutical Companies
- CROs and CMOs
- Academic and Research Institutes
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- ABM Industries Inc.
- Agilent Technologies Inc.
- Assay Genie Limited
- Bio-Rad Laboratories Inc.
- Charles River Laboratories International Inc. (Bausch & Lomb)
- Genewiz Inc (Azenta Life Sciences)
- Jena Bioscience GmbH
- Merck KGaA
- New England Biolabs Inc.
- Promega Corporation
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- TransGen Biotech Co. Ltd., etc.
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=8110&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group